- Research works
- 22 fractional, all time
- Citations
- 1.1k 50.5 per fractional work
- Top-10% rate
- 32.5% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Genaera (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Genaera (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Clinical Trials, Asthma, Genetics, Mutation Analysis, Allergic Diseases, Eosinophils and Treatment.
- Ovarian Cancer
- Mitochondria
- Reactive Oxygen Species
- Immune Modulation
- Chemotherapy
- Antimicrobial Peptides
- Innate Immunity
- Eosinophils
- Treatment
- Oxidative Stress
- Clinical Trials
- Epidemiology
- Inflammation
- Asthma
- Genetics
- Mutation Analysis
- Allergic Diseases
- Biomarkers
- Vascular Endothelial Growth Factor
- Cell Signaling
- Host Defense
- Membrane Proteins
- Genomic Analysis
- Mitochondrial Dysfunction
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Inflammation3▲ 6.3×8 topics
- Epidemiology2▲ 2.3×5 topics
- Asthma2▲ 66×2 topics
- Clinical Trials2▲ 14×4 topics
- Genetics2▲ 10×3 topics
- Oxidative Stress2▲ 4.5×3 topics
- Mutation Analysis2▲ 100×2 topics
- Treatment2▲ 5.9×2 topics
- Allergic Diseases2▲ 90×1 topic
- Eosinophils2▲ 90×1 topic
- Biomarkers1▲ 10×3 topics
- Innate Immunity1▲ 17×3 topics
- Vascular Endothelial Growth Factor1▲ 53×3 topics
- Antimicrobial Peptides1▲ 96×1 topic
- Cell Signaling1▲ 15×4 topics
- Chemotherapy1▲ 7.0×2 topics
- Host Defense1▲ 73×1 topic
- Immune Modulation1▲ 36×2 topics
- Membrane Proteins1▲ 27×2 topics
- Reactive Oxygen Species1▲ 9.7×2 topics
- Genomic Analysis1▲ 15×1 topic
- Mitochondria1▲ 27×1 topic
- Mitochondrial Dysfunction1▲ 12×1 topic
- Ovarian Cancer1▲ 48×1 topic
Which research topics does Genaera (United States) publish most on?
By volume: Asthma and respiratory diseases, Antimicrobial Peptides and Activities, Mitochondrial Function and Pathology and Ovarian cancer diagnosis and treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Asthma and respiratory diseases Physiology 2 works
- 2 Antimicrobial Peptides and Activities Microbiology 1 works
- 3 Mitochondrial Function and Pathology Molecular Biology 1 works
- 4 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
- 5 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 1 works
- 6 Retinal Diseases and Treatments Ophthalmology 1 works
- 7 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 1 works
- 8 Glaucoma and retinal disorders Ophthalmology 1 works
- 9 Lipid Membrane Structure and Behavior Molecular Biology 1 works
- 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Genaera (United States)'s research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Plymouth Meeting
- ECRI Institute
- Inovio Pharmaceuticals (United States)
- The Institute of Addiction Medicine
- Premier Dental Products (United States)
- Quietmind Foundation
- Claneil Foundation
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.